- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Occupational stress.
Displaying page 1 of 1.
| EudraCT Number: 2021-000319-21 | Sponsor Protocol Number: ClonDO | Start Date*: 2021-12-20 |
| Sponsor Name:Charité – Universitätsmedizin Berlin | ||
| Full Title: Treating Nightmares in Posttraumatic Stress Disorder with the α-adrenergic Agents Clonidine and Doxazosin: A Randomized-Controlled Feasibility Study (ClonDoTrial) | ||
| Medical condition: Posttraumatic Stress Disorder | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2007-001573-28 | Sponsor Protocol Number: Uni-Koeln-320 | Start Date*: 2007-11-26 |
| Sponsor Name:Universität zu Köln | ||
| Full Title: Prevent: Secondary Prevention of Schizophrenia. A randomized controlled trial. | ||
| Medical condition: Persons at risk of being prodromally symptomatic of psychosis (PAR) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2021-000862-14 | Sponsor Protocol Number: A-bipolar | Start Date*: 2021-07-08 | |||||||||||
| Sponsor Name:Copenhagen Affective Disorder research Center (CADIC), | |||||||||||||
| Full Title: Effects of low dose Aspirin in bipolar disorder – a randomized controlled trial (the A-Bipolar RCT) | |||||||||||||
| Medical condition: Bipolar disorder | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-000147-31 | Sponsor Protocol Number: 19-211 | Start Date*: 2022-11-09 | |||||||||||
| Sponsor Name:Clinical Evaluation Research Unit | |||||||||||||
| Full Title: VItamin C in Thermal injuRY: The VICToRY Pilot Trial A feasibility study for a seamless adaptive phase II/III multi-center randomized trial | |||||||||||||
| Medical condition: Severely burned patients | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-011003-23 | Sponsor Protocol Number: GFT505-209-4 | Start Date*: 2009-05-28 | ||||||||||||||||
| Sponsor Name:GENFIT | ||||||||||||||||||
| Full Title: A Pilot study to evaluate the Efficacy and Safety of GFT505 (80mg) orally administered once daily for 35 days in patients presenting with impaired glucose tolerance and abdominal obesity. A double ... | ||||||||||||||||||
| Medical condition: patients presenting with impaired glucose tolerance and abdominal obesity | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: FR (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2017-000246-21 | Sponsor Protocol Number: PP100-001 | Start Date*: 2017-04-25 | |||||||||||
| Sponsor Name:PledPharma AB | |||||||||||||
| Full Title: A Randomised Open Label Exploratory, Safety and Tolerability Study with PP100-01 in Patients Treated with the 12-hour Regimen of N-Acetylcysteine for Paracetamol/Acetaminophen Overdose | |||||||||||||
| Medical condition: The objective of this study is to develop a therapeutic regimen for paracetamol/acetaminophen overdose (POD) where a novel NAC 12hr regime is combined with a superoxide dismutase (SOD) mimetic, PP1... | |||||||||||||
|
|||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-000315-32 | Sponsor Protocol Number: 523079.01.113 | Start Date*: 2016-09-02 | |||||||||||
| Sponsor Name:Dr. Willmar Schwabe GmbH & Co. KG | |||||||||||||
| Full Title: Clinical Trial to Explore Treatment Effects of Ginkgo biloba Extract EGb 761® in Patients with Chronic Tinnitus and Effect Modification by Etiology, Biological Factors and Concomitant Pathologies. | |||||||||||||
| Medical condition: Chronic Tinnitus | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.